(Reuters) – Advisors to the European Medicines Agency (EMA) on Friday backed the use of a tetravalent dengue vaccine by the German unit of Japan’s Takeda for people aged four years and above.
(Reporting by Raghav Mahobe; Editing by Maju Samuel)
EU regulator adopts positive opinion for dengue vaccine
Oct 14, 2022 | 7:26 AM
Weather information is not currently available at this location.
